Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcome Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage NSCLC

NCT01237171 is registered in ClinicalTrials.gov with IsoRay Medical, Inc. as lead sponsor.

NCT NCT01237171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01237171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcome Study of Cesium-131 Brachytherapy Following Sub-Lobar Resection for Early Stage NSCLC
Lead sponsor
IsoRay Medical, Inc.
Phase
Observational
Overall status
Withdrawn
Start date
November 30, 2010
Completion date
November 30, 2010
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer, nsclc